BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 4363651)

  • 1. In vitro-in vivo studies on the susceptibility of the solid Yoshida sarcoma to drugs and hyperthermia (42 degrees).
    Dickson JA; Suzangar M
    Cancer Res; 1974 Jun; 34(6):1263-74. PubMed ID: 4363651
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of tumor volume and the degree of heating on the response of the solid Yoshida sarcoma to hyperthermia (40-42 degrees).
    Dickson JA; Ellis HA
    Cancer Res; 1976 Mar; 36(3):1188-95. PubMed ID: 1253175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metaphase-arresting action of carcinostatic tenuazonic acid.
    Hashimoto Y; Oshima H; Yuki H
    Gan; 1972 Feb; 63(1):79-85. PubMed ID: 5043818
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of hyperglycemia and hyperthermia on the pH, glycolysis, and respiration of the Yoshida sarcoma in vivo.
    Dickson JA; Calderwood SK
    J Natl Cancer Inst; 1979 Dec; 63(6):1371-81. PubMed ID: 41958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased lifespan by the sequential treatment with improsulfan and cyclophosphamide in rats bearing Yoshida ascites sarcoma.
    Okumoto T; Imamura H
    Chem Pharm Bull (Tokyo); 1976 Aug; 24(8):1913-6. PubMed ID: 184972
    [No Abstract]   [Full Text] [Related]  

  • 6. Synergistic effects of bis(3-methylsulfonyloxypropyl)-amine toluenesulfonate (864-T) with 6-mercaptopurine and other antitumor agents.
    Imamura H; Ikegami K; Okumoto T
    Gan; 1973 Oct; 64(5):427-31. PubMed ID: 4358730
    [No Abstract]   [Full Text] [Related]  

  • 7. A predictive in vitro assay for the sensitivity of human solid tumours to hyperthermia (42 degrees C) and its value in patient management.
    Dickson JA; Suzangar M
    Clin Oncol; 1976 Jun; 2(2):141-55. PubMed ID: 782754
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of chlorambucil treatment on the rates of respiration and glycolysis in drug-sensitive and -resistant strains of the Yoshida ascites sarcoma.
    Hill BT; Riches PG; Furness ME
    Biochem Pharmacol; 1970 Dec; 19(12):2973-8. PubMed ID: 5534949
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased production of alpha-fetoprotein by cyclic 3',5'-adenosine monophosphate-treated Yoshida ascites sarcoma cells in vitro.
    Isaka H; Umehara S; Umeda M; Hirai H; Tsukada Y
    Gan; 1974 Feb; 65(1):79-83. PubMed ID: 4133036
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitumor activity of improsulfan by the fractionated dose schedule on rat ascites tumors.
    Okumoto T; Imamura H
    Chem Pharm Bull (Tokyo); 1976 Nov; 24(11):2668-72. PubMed ID: 189948
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ineffectiveness of CH 23 in Yoshida sarcoma of the rat and mouse sarcoma 180].
    Schmähl D; Ballweg H; Berndt F; Osswald H
    Arzneimittelforschung; 1968 May; 18(5):588-9. PubMed ID: 5755887
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitumor effectiveness of improsulfan on nitrogen mustard-resistant Yoshida sarcoma cells.
    Okumoto T; Sugimoto N; Imamura H
    Chem Pharm Bull (Tokyo); 1977 Nov; 25(11):3003-8. PubMed ID: 203408
    [No Abstract]   [Full Text] [Related]  

  • 13. Carcinostatic combined therapy as viewed from its invasive effect on tumor cells.
    Takayama T; Konishi K; Hayasaka H; Nozaki S
    Int Surg; 1967 Aug; 48(2):180-8. PubMed ID: 6058195
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sensitivity tests of malignant tumours against cytostatic agents in vitro and in vivo/studies on the mouse sarcoma 180 (author's transl)].
    Volm M; Kaufmann M; Mattern J; Wayss K
    Arzneimittelforschung; 1975 Jul; 25(7):1042-8. PubMed ID: 52364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor inhibitory effect of a new series of methanesulfonate of aminoglycols.
    el-Merzabani MM; Ichimura H; Sato H; Sakurai Y
    Gan; 1973 Dec; 64(6):591-7. PubMed ID: 4360584
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of various chemotherapeutic agents on Sarcoma 37 ascites tumor cells.
    Johnston BJ; Mahood ME
    Acta Cytol; 1967; 11(2):98-103. PubMed ID: 4166197
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of various combined chemotherapeutic agents on sarcoma 37 ascites tumor cells. I.
    Johnston BJ; Mahood ME
    Acta Cytol; 1967; 11(5):383-9. PubMed ID: 4168137
    [No Abstract]   [Full Text] [Related]  

  • 18. A model system for examining the action of anti-cancer agents at the cellular level in vivo.
    Bruce WR
    Natl Cancer Inst Monogr; 1967 Feb; 24():249-56. PubMed ID: 6021079
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of various combined chemotherapeutic agents on sarcoma 37 ascites tumor cells. II.
    Johnston BJ; Mahood ME
    Acta Cytol; 1967; 11(5):390-6. PubMed ID: 4168138
    [No Abstract]   [Full Text] [Related]  

  • 20. Some effects of chlorambucil on the chromatin of Yoshida ascites sarcoma cells.
    Riches PG; Harrap KR
    Cancer Res; 1973 Feb; 33(2):389-93. PubMed ID: 4688885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.